Alopecia - Pipeline Review, H1 2018

  • ID: 4457544
  • Report
  • 153 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • Aclaris Therapeutics Inc
  • AndroScience Corp
  • BirchBioMed Inc
  • Cassiopea SpA
  • Japan Tobacco Inc
  • NovaLead Pharma Pvt Ltd
  • MORE
Alopecia - Pipeline Review, H1 2018

Summary

The latest Pharmaceutical and Healthcare disease pipeline guide Alopecia - Pipeline Review, H1 2018, provides an overview of the Alopecia (Dermatology) pipeline landscape.

Alopecia is the partial or complete loss of hair especially on the scalp either in patches, on the entire head or over the entire body. Thinning hair is the most obvious symptom. The predisposing factors include allergies, irritants, toxins, burns, injuries, and infections.

Report Highlights

The latest Pharmaceutical and Healthcare latest pipeline guide Alopecia - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Alopecia (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 1, 14, 6, 1, 18 and 10 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 2 molecules, respectively.

Alopecia (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from our proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Alopecia (Dermatology).
  • The pipeline guide reviews pipeline therapeutics for Alopecia (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Alopecia (Dermatology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Alopecia (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Alopecia (Dermatology)
Reasons to Buy:
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Alopecia (Dermatology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Alopecia (Dermatology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Aclaris Therapeutics Inc
  • AndroScience Corp
  • BirchBioMed Inc
  • Cassiopea SpA
  • Japan Tobacco Inc
  • NovaLead Pharma Pvt Ltd
  • MORE
Introduction

Alopecia - Overview

Alopecia - Therapeutics Development

Alopecia - Therapeutics Assessment

Alopecia - Companies Involved in Therapeutics Development

Alopecia - Drug Profiles

Alopecia - Dormant Projects

Alopecia - Discontinued Products

Alopecia - Product Development Milestones

Appendix

List of Tables

Number of Products under Development for Alopecia, H1

Number of Products under Development by Companies, H1

Number of Products under Development by Universities/Institutes, H1

Products under Development by Companies, H1

Products under Development by Universities/Institutes, H1

Number of Products by Stage and Target, H1

Number of Products by Stage and Mechanism of Action, H1

Number of Products by Stage and Route of Administration, H1

Number of Products by Stage and Molecule Type, H1

Alopecia - Pipeline by Aclaris Therapeutics Inc, H1

Alopecia - Pipeline by Allergan Plc, H1

Alopecia - Pipeline by Almirall SA, H1

Alopecia - Pipeline by AndroScience Corp, H1

Alopecia - Pipeline by Berg LLC, H1

Alopecia - Pipeline by BiologicsMD Inc, H1

Alopecia - Pipeline by BirchBioMed Inc, H1

Alopecia - Pipeline by Brickell Biotech Inc, H1

Alopecia - Pipeline by Bristol-Myers Squibb Co, H1

Alopecia - Pipeline by Cassiopea SpA, H1

Alopecia - Pipeline by Concert Pharmaceuticals Inc, H1

Alopecia - Pipeline by Daewoong Pharmaceutical Co Ltd, H1

Alopecia - Pipeline by Energenesis Biomedical Co Ltd, H1

Alopecia - Pipeline by Histogen Inc, H1

Alopecia - Pipeline by Hyundai Pharmaceutical Co Ltd, H1

Alopecia - Pipeline by Incyte Corp, H1

Alopecia - Pipeline by Japan Tobacco Inc, H1

Alopecia - Pipeline by JW Pharmaceutical Corp, H1

Alopecia - Pipeline by Kuhnil Pharmaceutical Co Ltd, H1

Alopecia - Pipeline by Lee's Pharmaceutical Holdings Ltd, H1

Alopecia - Pipeline by Medivir AB, H1

Alopecia - Pipeline by NovaLead Pharma Pvt Ltd, H1

Alopecia - Pipeline by Pfizer Inc, H1

Alopecia - Pipeline by Quark Pharmaceuticals Inc, H1

Alopecia - Pipeline by RXi Pharmaceuticals Corp, H1

Alopecia - Pipeline by Samumed LLC, H1

Alopecia - Pipeline by Switch Biotech LLC, H1

Alopecia - Pipeline by Taisho Pharmaceutical Holdings Co Ltd, H1

Alopecia - Pipeline by Tigo GmbH, H1

Alopecia - Dormant Projects, H1

Alopecia - Discontinued Products, H1

List of Figures

Number of Products under Development for Alopecia, H1

Number of Products under Development by Companies, H1

Number of Products by Top 10 Targets, H1

Number of Products by Stage and Top 10 Targets, H1

Number of Products by Top 10 Mechanism of Actions, H1

Number of Products by Stage and Top 10 Mechanism of Actions, H1

Number of Products by Routes of Administration, H1

Number of Products by Stage and Routes of Administration, H1

Number of Products by Top 10 Molecule Types, H1

Number of Products by Stage and Top 10 Molecule Types, H
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Aclaris Therapeutics Inc
  • Allergan Plc
  • Almirall SA
  • AndroScience Corp
  • Berg LLC
  • BiologicsMD Inc
  • BirchBioMed Inc
  • Brickell Biotech Inc
  • Bristol-Myers Squibb Co
  • Cassiopea SpA
  • Concert Pharmaceuticals Inc
  • Daewoong Pharmaceutical Co Ltd
  • Energenesis Biomedical Co Ltd
  • Histogen Inc
  • Hyundai Pharmaceutical Co Ltd
  • Incyte Corp
  • Japan Tobacco Inc
  • JW Pharmaceutical Corp
  • Kuhnil Pharmaceutical Co Ltd
  • Lee's Pharmaceutical Holdings Ltd
  • Medivir AB
  • NovaLead Pharma Pvt Ltd
  • Pfizer Inc
  • Quark Pharmaceuticals Inc
  • RXi Pharmaceuticals Corp
  • Samumed LLC
  • Switch Biotech LLC
  • Taisho Pharmaceutical Holdings Co Ltd
  • Tigo GmbH
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll